Preoperative tear volume may affect LASIK recovery

Article

Preoperative tear volume may affect recovery of the ocular surface after LASIK and could increase the risk for chronic dry eye.

Preoperative tear volume may affect recovery of the ocular surface after LASIK and could increase the risk for chronic dry eye, according to a study published in the January issue of Investigative Ophthalmology & Visual Science.

Keiko Konomi and colleagues from the Schepens Eye Research Institute, Boston, USA enrolled 24 patients undergoing LASIK. Tear break-up time, Schirmer testing with and without anaesthesia, rose bengal staining, central corneal sensitivity, nucleus-to-cytoplasmic ratio and globlet cell density were evaluated two weeks prior to surgery and one week, three months and nine months after surgery. Subjects were classified into two outcome groups, the non-dry eye group (NDEG) and the chronic dry eye group (CDEG), on the basis of dry eye status nine months after surgery.

All parameters, except rose bengal staining, deteriorated significantly after surgery but returned to preoperative levels within three to nine months. The CDEG group had significantly lower preoperative Schirmer test values with an without anaesthesia and were delayed in recovery after surgery in globlet cell density, rose bengal staining, Schirmer test values without anaesthesia and tear break-up time. Results of preoperative Schirmer tests without anaesthesia positively correlated with tear break-up time nine months after surgery.

The authors believe that these findings may help ophthalmologists to determine if pre-treatment is necessary before surgery or if surgery is appropriate at all.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.